Presenting Company Session
|
Comphya SA
Comphya is a swiss medical device company developing the first implantable neurostimulator to restore the erectile function of patients who are non-responsive to oral drugs (e.g. Viagra). Today, these patients resort to painful, problematic and outdated methods such as intrapenile injections or penile prosthesis. Comphya fills the need for better modalities, with a more comfortable, efficacious and safe treatment. Our proven technology consists of implanting a neuro-stimulator in the pelvic cavity, which will selectively activate the pro-erectile nerves to restore natural penile erection. The main target segments are spinal cord injury and prostatectomy patients, a CHF100M and 1B market, respectively.
www.comphya.com |
|
Gondola Medical Technologies SAGondola Medical Technologies SA is a Swiss based company that has developed the Gondola® device, a patented medical device to treat walking and balance impairments due to neurological conditions.
It is effective in treating invalidating mobility problems caused by Parkinson’s disease and stroke. Currently these symptoms do not have adequate treatment options. Gondola® device efficacy has been scientifically documented. Gondola® is CE marked and bears FDA Breakthrough Devices designation. FDA marketing authorization is expected by end of 2023. Patents have been granted in USA, Canada, Europe, China, Israel, Japan, and several other geographies. www.gondola-medical.com/ |
|
Lambda Health System SA
LHS is a rehabilitation robotic spin-off from the University Hospital of Lausanne (CHUV). It is certified ISO13485 and has a first class IIa CE marked product: the Lambda. 4 devices were installed at 3 clients' premises since June 2020 and there are a lot of promising prospects for 2022. The company raised 2.2 MCHF including non-dilutive helps and loans. A series A round of 3MCHF is planned for the first quarter of 2023 triggered by convertible loans during the second semester of 2022.
We are looking forward to meet you during this event to redesign together the physical rehabilitation of tomorrow. www.lhs-sa.ch |
|
Neurosoft Bioelectronics SA
Neurosoft Bioelectronics develops and manufactures soft implantable electrodes to record from and electrically stimulate the surface of the brain to monitor and treat severe neurological disorders.
www.neurosoft-bio.com |
|
SensArs Neuroprosthetics Sarl
SensArs’ is an EPFL spinoff that was founded by pioneers in neuromodulation and neuroprosthetics, having made the first European implants of electrodes in amputees’ nerves for the restoration of sensory feedback from their prosthesis. SensArs develops and commercializes nerve stimulators, which unlike competition, access fibers inside the nerve, maximizing stimulation selectivity. We target 7% of the world population affected by peripheral neuropathies, i.e. nerve damage that causes movement disabilities due to sensory loss and chronic pain.
www.sensars.com |
|